Janet S. Vergis
CIK 1590794 · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.82M
Companies
5
Total Filings
80
Lifetime Open-Market Net
-$3.65M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CHD | Director | 21,188 | $99.43 | $2.11M | -$3.65M | 31 | 2026-07-02 |
| XRAY | Director | 67,324 | $10.76 | $724.4K | $0 | 31 | 2026-06-05 |
| TEVA | Director | 73,697 | $36.19 | $2.67M | $0 | 10 | 2025-06-09 |
| AMRX | Director | 18,257 | $17.68 | $322.8K | $0 | 2 | 2019-05-08 |
| Impax Laboratories, LLC (IPXL) Delisted | Director | 12,150 | — | — | $0 | 3 | 2017-05-17 |
Recent Filings · Page 5 of 8
80 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-07-13 | XRAY | Grant (A) | +5 | $331 | EDGAR |
| 2021-07-01 | CHD | Grant (A) | +1,409 | $120.1K | EDGAR |
| 2021-06-16 | TEVA | Grant (A) | — | $0 | EDGAR |
| 2021-06-15 | CHD | Grant (A) | — | $0 | EDGAR |
| 2021-06-10 | TEVA | Exer (M) | +12,668 | $0 | EDGAR |
| 2021-06-01 | XRAY | Grant (A) | +3,008 | $0 | EDGAR |
| 2021-04-12 | XRAY | Grant (A) | +7 | $0 | EDGAR |
| 2021-01-12 | XRAY | Grant (A) | +9 | $0 | EDGAR |
| 2020-10-13 | XRAY | Grant (A) | +15 | $0 | EDGAR |
| 2020-08-05 | CHD | Mixed | — | -$786.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.